AgingResearch.NewsJoin free

Probable Long COVID

There is 1 paper on probable Long COVID in aging research: 1 observational study in people. The newest story, Nov 6, 2026: “Metformin linked to lower death risk after COVID-19 in diabetes”.

Disease

1 paper studies it1 finding

1 new paper in 30 daysSee all 1 papers on probable Long COVID

“metformin users, compared to DPP4i users, had a slightly lower risk of probable Long COVID (aRR: 0.87, 95% CI: 0.81, 0.94)”
Metformin and Severe Post‐ <scp>COVID</scp> ‐19 Outcomes Among Individuals With Diabetes MellitusDiabetes, obesity & metabolism2026doi:10.1111/dom.71502
  • Humans1

Associations

1

Metformin

downin humans1

1 study

  1. Metformin is associated with probable Long COVID in humans (aRR 0.87, 95% CI 0.81–0.94).

    “metformin users, compared to DPP4i users, had a slightly lower risk of probable Long COVID (aRR: 0.87, 95% CI: 0.81, 0.94)”

    HumansType 2 diabetes and COVID-19; model-derived phenotype; compared with DPP4 inhibitor prescription12 monthsn = 53,332

    Metformin linked to lower death risk after COVID-19 in diabetes

    Diabetes, obesity & metabolism

More on Metformin

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
Diabetes, Obesity & Metabolism

Metformin linked to lower death risk after COVID-19 in diabetes

Over 12 months, the adjusted risk ratio for death was 0.61 for metformin prescriptions versus prescriptions for another diabetes drug.Over 12 months, the adjusted risk ratio for death was 0.61 for metformin prescriptions versus prescriptions for another diabetes drug.

Cohort · 53,332 peopleCOVID-19
Paper

Related